Ready-to-use, fast, consistent and automated algorithm for clinical decision support
The Roche uPath HER2 Dual ISH image analysis for Breast algorithm is intended for use as an aid to the pathologist to determine HER2 gene status by enumeration of the ratio of the HER2 gene to Chromosome17, in formalin-fixed, paraffin-embedded neoplastic breast tissue specimens. When used with the VENTANA HER2 Dual ISH assay, it is indicated as an aid in the assessment of breast cancer patients for whom treatment is being considered.
Validated on VENTANA HER2 Dual ISH DNA Probe Cocktail assay, for use within Roche uPath enterprise software.
Pathologist-trained artificial intelligence algorithm for quick image analysis.
Actionable assessment of scanned slide images that are objective and reproducible, aiding in informing on potential treatment strategies.